SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    ReisLAG, EisnerMP, KosaryCL, et al., editors. SEER cancer statistics review: 1973–1997. Bethesda: National Cancer Institute, 2000.
  • 2
    Chevarley F, White E. Recent trends in breast cancer mortality among white and black U.S. women. Am J Public Health. 1997;87: 775781.
  • 3
    Chu KC, Tarone RE, Kessler LG, et al. Recent trends in U.S. breast cancer incidence, survival and mortality rates. J Natl Cancer Inst. 1996;88: 15711579.
  • 4
    Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer. 1989; 59: 954958.
  • 5
    Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989; 63: 181187.
  • 6
    Maibenco D, Daoud Y, Phillips E, Saxe A. Relationship between method of detection of breast cancer and stage of disease, method of treatment and survival in women aged 40 to 49 years. Am Surg. 1999; 65: 10611066.
  • 7
    Nakhleh RE, Zarbo RJ. Surgical pathology-based outcomes assessment of breast cancer early diagnosis. Arch Pathol Lab Med. 2001; 125: 325331.
  • 8
    Dee KE, Sickles EA. Medical audit of diagnostic mammography examinations: comparison with screening outcomes obtained concurrently. Am J Roentgenol. 2001; 176: 729733.
  • 9
    Hunt KA, Rosen EL, Sickles EA. Outcome analysis for women undergoing annual versus biennial screening mammography: a review of 24,211 examinations. Am J Roentgenol. 1999; 173: 285289.
  • 10
    Wu Y, Weissfeld JL, Weinberg GB, Kuller LH. Screening mammography and late-stage breast cancer: a population-based study. Prev Med. 1999; 28: 572578.
  • 11
    McCarthy EP, Burns RB, Freund KM, et al. Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc. 2000; 48: 12261233.
  • 12
    Vermont Department of Health. Cancer in Vermont: a report of 1994–1996 cancer incidence data from the Vermont Cancer Registry. Burlington: Vermont Department of Health, 2000.
  • 13
    Farwell MF, Foster RS, Costanza MC. Breast cancer and earlier detection efforts: realized and unrealized impact on stage. Arch Surg. 1993; 128: 510513.
  • 14
    Foster RS, Farwell ME, Costanza MC. Breast-conserving surgery for breast cancer: patterns of care in a geographic region and estimation of potential applicability. Ann Surg Oncol. 1995; 2: 275280.
  • 15
    Geller BM, Worden JK, Ashley JA, Oppenheimer RG, Weaver DL. Multipurpose statewide breast cancer surveillance system: the Vermont experience. J Registry Manage. 1996; 23: 168174.
  • 16
    Cady B, Stone MD, Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg. 1993; 218: 338349.
  • 17
    Division of Cancer Prevention and Control, National Cancer Institute. 1987 Annual cancer statistics review including cancer trends: 1950–1985. DHHS publication no. 88-2789. Bethesda: National Institutes of Health, 1988.
  • 18
    Degnan D, Harris R, Ranney J, Quade D, Earp JA, Gonzalez J. Measuring the use of mammography: two methods compared. Am J Public Health. 1992; 82: 13861388.
  • 19
    King ES, Rimer BK, Trock B, Balshem A, Engstrom P. How valid are mammography self-reports? Am J Public Health. 1990; 80: 13861388.
  • 20
    Fulton-Kehoe D, Burg MA, Lane DS. Are self-reported dates of mammograms accurate? Public Health Rev. 1992; 20: 233240.
  • 21
    Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the international workshop on screening for breast cancer. J Natl Cancer Inst. 1993; 85: 16441656.
  • 22
    Feig SA. Benefits and risks of mammography. Recent Results Cancer Res. 1984; 90: 1127.
  • 23
    Foster RS. The biologic and clinical significance of lymphatic metastases in breast cancer. Surg Oncol Clin North Am. 1996; 5: 79104.
  • 24
    Holmberg L, Lindgren A, Norden T, Adami HO, Bergstrom R. Age as a determinant of axillary node involvement in invasive breast cancer. Acta Oncol. 1992; 31: 533538.